The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary efficacy and safety of camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase II clinical trial.
 
Dongmei Ji
No Relationships to Disclose
 
Youzhou Sang
No Relationships to Disclose
 
Xin Liu
No Relationships to Disclose
 
Yanjing Guo
No Relationships to Disclose
 
Yanan Yang
No Relationships to Disclose
 
Guangliang Chen
No Relationships to Disclose
 
Shu Dong
No Relationships to Disclose
 
Yulong Wang
No Relationships to Disclose
 
Xiayun He
No Relationships to Disclose
 
Hongmei Ying
No Relationships to Disclose
 
Xueguan Lu
No Relationships to Disclose
 
Yu Wang
No Relationships to Disclose
 
Chaosu Hu
No Relationships to Disclose
 
Qinghai Ji
No Relationships to Disclose